Trial intelligence / Profile preview

Antioxidant Vitamins for Coagulopathy and Pneumonia in Trauma

NCT01897792Phase 2Terminated

Sponsor
University of Alabama at Birmingham
Start
May 2013
Primary completion
Feb 2015
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of ascorbic acid, vitamin e in coagulopathy, hospital-acquired pneumonia (HAP), sponsored by University of Alabama at Birmingham. Started May 2013; status: terminated.

02

Drugs

ascorbic acidvitamin e
03

Conditions

coagulopathyhospital-acquired pneumonia (HAP)

Beyond the preview

Go deeper on NCT01897792.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01897792.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call